PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The private market for tuberculosis drugs

Big and messy, but a necessary partner in stopping the TB epidemic

2011-05-05
(Press-News.org) (May 4, 2011, NEW YORK, USA) Tuberculosis (TB) is widely considered a public health concern and its treatment a public sector responsibility. But according to a study published today in the journal PLoS ONE, the private sector for TB treatment is ignored at our peril. Across 10 high-burden countries, there is as much TB drug volume in the private sector as in the public sector—and at least a third of all private sector dosages of first-line TB drugs fall outside of national and international treatment recommendations. Any resulting drug misuse could be responsible for many treatment failures and for escalating the emergence of multidrug-resistant TB (MDR-TB), which is further worsening the TB epidemic.

The research, conducted by the TB Alliance and IMS Health (a healthcare market research and consulting-services firm), is the first detailed study of the private TB drug market across multiple high-burden countries. Sixty percent of the world's TB burden is present in the 10 study countries (Bangladesh, China, India, Indonesia, Pakistan, Philippines, Russian Federation, South Africa, Thailand, and Viet Nam).

TB treatment requires lengthy, supervised treatment to maximize cure rates and minimize the development of drug resistance, and in low-income settings this task is thought to be more achievable in the public sector. By contrast, the private sector treatment landscape in these countries is largely unregulated and fragmented; for example, the study detected 111 different first-line TB drug dosages and combinations, compared to the 14 deemed necessary by the Stop TB Partnership's Global Drug Facility.

"The private sector is keeping alive the confusion that existed previously in the public sector," said Dr. William Wells, the study's lead author and Director of Market Access at the TB Alliance. "With this new baseline understanding of the TB drug market, we can no longer ignore the private sector's critical role in the access equation for TB treatment and in the task of protecting both current drugs and new regimens from the development of resistance."

Other key findings revealed that:

The public and private sectors are both major channels of treatment for TB patients. Nearly equal amounts of TB drugs are dispensed in the public and private sectors (enough to treat 67 percent vs. 66 percent of estimated incidence, respectively). The size of the private sector for TB drugs varies between countries, but has been steady within most countries over the past 5 years.

Four of the biggest high-burden countries – India, Indonesia, Pakistan, and Philippines – had particularly large private sectors. Enough TB drugs are sold in their private sectors to treat all, or nearly all, incident TB patients with a full TB drug regimen. This is without even considering the 60 to 80 percent coverage by the public sector.

Few patients receive MDR-TB treatment in the public sector—and the data reveal that the private sector is not stepping in to fill the gap. Private sector sales have the capacity to cover only ~1-10% of MDR-TB patients (or 0%, in three study countries) with anything approaching a full regimen. However, with new, rapid diagnostics becoming available, this market may expand rapidly, thus highlighting the urgency for action now.

"During the past decade, the world has seen a reawakening of TB drug development efforts, and the first wave of new TB treatments will be introduced within the next few years," said Dr. Mel Spigelman, President and CEO of the TB Alliance. "This study fills a critical gap in our knowledge base."

"Most countries covered in this study have public-private mix (PPM) programmes for TB care," said Mario Raviglione, Director of the Stop TB Department at the World Health Organization. "Based on country experiences, these programmes have shown good results in optimizing TB management by private care providers. However, the size of the response is not commensurate with the size of the challenge; there is enormous scope to expand these programmes urgently. Private providers following best practices should be supported through accreditation and access to free TB drugs from the public sector, while those not doing so should be regulated. Greater government and international support is needed for these efforts and also for improved regulatory oversight and quality assurance of TB drugs. A dual track approach of collaboration and regulation is the logical way forward. We ought to make private providers responsible partners of the public sector in controlling TB and MDR-TB".

###

About Tuberculosis

TB kills nearly 2 million people each year, mostly in the developing world. One of the drivers of the epidemic is the old and inadequate treatment. There have been no new TB drug classes for nearly 50 years and the current regimens available take 6-9 months, and are too long and complex for resource-poor settings. Because of that, many patients are unable to complete their drug regimen, which leads to drug resistance, an emerging global health threat. The treatment for drug-resistant TB can take two years or longer, involve multiple drugs and injectables, and is much more expensive than the first-line treatment. According to WHO, there were 440,000 cases of multidrug-resistant TB in 2008; for those MDR-TB patients who were able to access MDR-TB treatment, at least a third still died.

About the Global Alliance for TB Drug Development

The Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis. Through innovative science and with partners around the globe, we aim to ensure equitable access to faster, better TB cures that will advance global health and prosperity. The TB Alliance operates with funding from the Bill & Melinda Gates Foundation, the United Kingdom Department for International Development, the United States Agency for International Development, the European Commission, and the United States Food and Drug Administration. For more information please visit www.tballiance.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

AgreeYa Launches Desktop as a Service (DaaS) Offering for Small and Medium Business Segment

AgreeYa Launches Desktop as a Service (DaaS) Offering for Small and Medium Business Segment
2011-05-05
AgreeYa Solutions, Inc., announced today that it has launched a new offering to provide Desktop As A Service (DaaS), a new cost-effective service to deploy cloud-based desktops that features zero upfront costs, no software or hardware to deploy, and flexible deployment and pricing options. This new service will be delivered in conjunction with Webion's enterprise-class data center, Quest Software's vWorkspace product for desktop virtualization management, and AgreeYa's managed service environment, to give customers virtual desktops at a significantly lower cost than ...

Air pollution near Michigan schools linked to poorer student health, academic performance

2011-05-05
ANN ARBOR, Mich.---Air pollution from industrial sources near Michigan public schools jeopardizes children's health and academic success, according to a new study from University of Michigan researchers. The researchers found that schools located in areas with the state's highest industrial air pollution levels had the lowest attendance rates---an indicator of poor health---as well as the highest proportions of students who failed to meet state educational testing standards. The researchers examined the distribution of all 3,660 public elementary, middle, junior high ...

Systematic effort helps hospital raise employee flu vaccination rates

2011-05-05
A systematic effort to improve flu vaccination rates for healthcare workers has increased flu vaccinations rates from 59 percent to 77 percent at the University Health System (UHS) in San Antonio. A report detailing their interventions to increase vaccination was published in the June issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. UHS raised its healthcare worker vaccination rate from 59 percent in 2009 to 77 percent in 2010 through quality improvement tools including vaccine kits to individual ...

Race in America

2011-05-05
EVANSTON, Ill. --- Four Northwestern University scholars authored or co-authored three essays in "Race, Inequality, and Culture." In the new issue of Daedalus, the Journal of the American Academy of Arts and Sciences, 22 prominent social scientists examine race in America today, weighing in on topics ranging from the future of African American studies to intra-minority group relations in the 21st century. Has the mission of African American studies changed? How is the old racial order being transformed? How will racial minorities react to the predicted demographic shifts ...

Childhood cancer survivors are at increased risk for ongoing post-therapy GI complications

2011-05-05
Patients who received therapy for cancer during childhood have an increased risk of developing gastrointestinal (GI) complications later in life, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. Compared with their siblings, cancer survivors had an increased risk of late-onset complications of the upper GI tract, lower GI tract and liver. "Survivors are at elevated risk for ongoing gastrointestinal complications after therapy," said Robert Goldsby, MD, of the University of California, San ...

Scandinavia's Biggest Shopping Chain Chooses WebProof.

2011-05-05
WebProof in Roskilde has yet again proven that Danish IT, based on unique, innovative program development, can be a global player. "As one of the established and biggest software providers in online proofing, we were invited to give suggestions on how WebProof would satisfy the detailed specification requirements that ICA had put forward, especially including requirements to security, up-time and speed. We must have shown this very well via online meetings and workshops," states CEO Jan Adeltoft, and continues "I have great respect for the thoroughness ...

Comprehensive study finds no link between XMRV retrovirus and chronic fatigue syndrome

2011-05-05
(SALT LAKE CITY)— New findings from University of Utah School of Medicine researchers show that the retrovirus called XMRV is not present in the blood of patients who have chronic fatigue syndrome (CFS). These findings contradict a widely reported 2009 Science study that linked CFS to XMRV. The study, performed by a team of U of U researchers led by Ila R Singh, M.D., Ph.D., associate professor of pathology, was published May 4, 2011, in the Journal of Virology online, and is the most comprehensive to date regarding the purported link between chronic fatigue syndrome ...

Positive effects of depression

2011-05-05
Sadness, apathy, preoccupation. These traits come to mind when people think about depression, the world's most frequently diagnosed mental disorder. Yet, forthcoming research in the Journal of Abnormal Psychology provides evidence that depression has a positive side-effect. According to a new study by Bettina von Helversen (University of Basel, Switzerland), Andreas Wilke (Clarkson University), Tim Johnson (Stanford University), Gabriele Schmid (Technische Universität München, Germany), and Burghard Klapp (Charité Hospital Berlin, Germany), depressed individuals perform ...

Researchers discover protein that could help prevent the spread of cancer

Researchers discover protein that could help prevent the spread of cancer
2011-05-05
A protein capable of halting the spread of breast cancer cells could lead to a therapy for preventing or limiting the spread of the disease. "Cancer researchers want to design new therapeutic strategies in which the metastasis or spreading stage of cancer can be blocked," explains Andrew Craig, lead researcher and a professor in Queen's Department of Biochemistry and Cancer Research Institute. "Patients stand a much better chance of survival if the primary tumor is the only tumor that needs to be treated." The regulatory protein identified by Dr Craig's team inhibits ...

BestPokerRooms Weighs Remaining Options For US Poker Players

2011-05-05
The fallout from Black Friday -when the US government seized the domain names of the three largest online poker rooms operating inside the United States, PokerStars, Full Tilt Poker, and the Cereus Poker Network of Absolute Poker and UB Poker--has gone beyond simply affecting these three online poker giants, and a number of smaller sites have also decided to leave the US market in the wake of the government crackdown. Three of the sites that have decided to forego the US online poker market are Victory Poker, which operates on the Cake Poker Network; and Sportsbook Poker ...

LAST 30 PRESS RELEASES:

Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology

'Glass fences' hinder Japanese female faculty in international research, study finds

Vector winds forecast by numerical weather prediction models still in need of optimization

New research identifies key cellular mechanism driving Alzheimer’s disease

Trends in buprenorphine dispensing among adolescents and young adults in the US

Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility

Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity

Association of state cannabis legalization with cannabis use disorder and cannabis poisoning

Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders

Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals

Unlocking the mysteries of the human gut

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

[Press-News.org] The private market for tuberculosis drugs
Big and messy, but a necessary partner in stopping the TB epidemic